{"id":59564,"date":"2024-08-05T06:00:07","date_gmt":"2024-08-05T10:00:07","guid":{"rendered":"https:\/\/www.ino.com\/blog\/?p=59564"},"modified":"2024-08-19T09:02:40","modified_gmt":"2024-08-19T13:02:40","slug":"medicare-for-all-how-harris-plan-could-reshape-healthcare-investments","status":"publish","type":"post","link":"https:\/\/wwwtest.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/","title":{"rendered":"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments"},"content":{"rendered":"

As Kamala Harris\u2019s 2024 presidential campaign gains momentum, her aggressive stance on Medicare expansion and potentially eliminating private health insurance is drawing significant attention. Harris has been a long-standing advocate for Medicare for All, including supporting Bernie Sanders\u2019 bill to eliminate private insurance for all age groups.<\/span><\/p>\n

The ambitious plan by Kamala Harris could have profound implications for individual healthcare costs, such as out-of-pocket expenses for retirees and investment opportunities across the healthcare sector. This article delves into the ramifications for major medical stocks like<\/span> CVS Health Corporation (CVS)<\/span><\/a>,<\/span> Teladoc Health, Inc. (TDOC)<\/span><\/a>,<\/span> Abbott Laboratories (ABT)<\/span><\/a>, and<\/span> Johnson & Johnson (JNJ)<\/span><\/a>.<\/span><\/p>\n

Kamala Harris\u2019 Stance on Medicare Expansion<\/b><\/p>\n

Over the years, Harris has<\/span> consistently championed<\/span><\/a> Medicare for all, aligning with Senator Bernie Sanders\u2019s vision of a single-payer healthcare system. Her proposal envisions a significant expansion of Medicare, extending coverage to all Americans and eliminating the need for private health insurance. She has remained among the more outspoken Democratic politicians promoting government-led insurance programs.<\/span><\/p>\n

In 2017, Harris was the first senator to co-sponsor Bernie Sanders\u2019s bill, the<\/span> Medicare for All Act of 2017<\/span><\/a>. If enacted, that bill would abolish private health insurance for all age groups, including Medicare beneficiaries, and replace it with a government-run single-payer system to benefit every resident of the United States, including undocumented immigrants.<\/span><\/p>\n

On January 21, 2019, Harris announced her intention to run for the 2020 Democratic nomination for President. A few days later, during a CNN town hall event in Iowa, she<\/span> elaborated<\/span><\/a> on her reasons for aiming to eliminate \u201cinhumane\u201d private insurance.<\/span><\/p>\n

\u201cWell, listen, the idea is that everyone gets access to medical care, and you don\u2019t have to go through the process of going through an insurance company, having them give you approval, going through the paperwork, all of the delay that may require,\u201d Harris said. \u201cWho of us has not had that situation where you\u2019ve got to wait for approval, and the doctor says, well, I don\u2019t know if your insurance company is going to cover this. Let\u2019s eliminate all of that. Let\u2019s move on.\u201d<\/span><\/p>\n

Although Harris reversed herself multiple times in 2019, she remained committed to the broader goal of Medicare for All. On July 29, 2019, Harris unveiled a detailed outline of what she termed \u201c<\/span>my plan for Medicare for all<\/span><\/a>,\u201d which featured significant differences from both Bernie Sanders\u2019s version and the various versions she had previously endorsed.<\/span><\/p>\n

Like the Sanders bill, Harris\u2019s new plan would eliminate employer-sponsored insurance, Affordable Care Act exchange plans, Medicaid, and other existing programs, replacing them with Medicare-based coverage. However, unlike Sanders\u2019s proposal, Harris\u2019 July 2019 plan would permit private insurers to continue offering Medicare Advantage-style coverage, albeit with lower reimbursement rates compared to traditional Medicare.<\/span><\/p>\n

Additionally, while Sanders\u2019s bill includes a four-year transition period to single-payer healthcare, Harris\u2019s plan proposed a 10-year transition to the new system.<\/span><\/p>\n

If Kamala Harris wins the 2024 presidential election, she is expected to advance her Medicare for All agenda, which could lead to significant changes in the U.S. healthcare system.<\/span><\/p>\n

\u201cShe is a strong advocate for both [Social Security and Medicare] and is keen on expanding them,\u201d<\/span> stated<\/span><\/a> Aaron Cirksena, CEO of MDRN Capital, a retirement planning firm. \u201cThis includes protecting benefits from any cuts and expanding the reach of coverage.\u201d<\/span><\/p>\n

\u201cThese plans may mean an increase in government spending and taxes, likely for upper-class earners,\u201d Cirksena explained. \u201cIt may also mean lower out-of-pocket healthcare expenses and easier access to services for retirees.\u201d<\/span><\/p>\n

Implications for Healthcare Stocks<\/b><\/p>\n

The proposed Medicare for all plan could lead to a significant restructuring of the healthcare sector, with wide-ranging economic implications. Expanding Medicare would likely result in a surge in government healthcare spending. It could also affect individual costs, including out-of-pocket expenses for retirees.<\/span><\/p>\n

Moreover, the shift towards a more government-controlled healthcare system may create new investment opportunities in areas such as telemedicine, retail pharmacy services, and health technology. Companies that can adapt to the changing landscape and align with government priorities may find growth opportunities.<\/span><\/p>\n

Insurers:<\/b> CVS Health Corporation (CVS)<\/span><\/a> is a prominent health solutions company broadening medical access for millions of people globally. The company provides private insurance through its subsidiary, Aetna, which offers a range of insurance products, including individual and family health plans, employer-sponsored plans, and Medicare Advantage plans.<\/span><\/p>\n

The potential reduction in the role of private insurance under the Harris administration could impact CVS\u2019 insurance operations, including Aetna. It might lead CVS to pivot more towards its retail pharmacy and healthcare services, influencing its strategic direction. CVS Health stands to benefit considerably from the proposed Medicare expansion, potentially boosting the company\u2019s profitability and growth.<\/span><\/p>\n

While there are several opportunities for CVS to benefit from Medicare expansion, the actual impact would depend on the specifics of the policy changes and how the company adapts to and capitalizes on these changes.<\/span><\/p>\n

Telehealth Providers:<\/b> Teladoc Health, Inc. (TDOC)<\/span><\/a> can benefit from increased demand for telemedicine services under a Medicare for all plan. The company operates through Teladoc Health Integrated Care and BetterHelp segments, providing virtual healthcare services, including general medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.<\/span><\/p>\n

As access to healthcare is likely to become broader under Kamala Harris\u2019 proposed plan, TDOC is positioned to cater to a growing patient base seeking virtual medical services, driving the company\u2019s revenue streams and market reach.<\/span><\/p>\n

Pharmaceutical and Medical Device Companies:<\/b> Johnson & Johnson (JNJ)<\/span><\/a> is a global leader in the healthcare industry, known for its extensive range of products spanning pharmaceuticals, medical devices, and consumer health. Johnson & Johnson stands to gain from Harris\u2019 Medicare for All plan through increased demand for its healthcare products, as well as potential opportunities for strategic partnerships and government contracts.<\/span><\/p>\n

The expanded Medicare coverage could enhance J&J\u2019s market reach and provide a more stable financial environment for its diverse healthcare offerings.<\/span><\/p>\n

Abbott Laboratories (ABT)<\/span><\/a>, another key player in medical devices and branded generic pharmaceuticals, could benefit from Kamala Harris\u2019 proposed plan. Increased Medicare coverage might drive higher demand for medical devices and diagnostic tests. Abbott may also find opportunities for collaboration with government agencies and healthcare systems to integrate its solutions into the expanded Medicare framework, potentially enhancing its market presence.<\/span><\/p>\n

Bottom Line<\/b><\/p>\n

Vice President Kamala Harris\u2019 Medicare for All proposed plan represents a transformative vision for the U.S. healthcare system, potentially reshaping individual healthcare costs and impacting major healthcare stocks. The expansion of Medicare promises reduced out-of-pocket expenses and broader coverage and provides opportunities for healthcare companies like CVS, TDOC, ABT, and JNJ.<\/span><\/p>\n

Investors should stay attuned to the evolving policy landscape in the healthcare sector and consider how these developments might influence investment strategies and market dynamics.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"

As Kamala Harris\u2019s 2024 presidential campaign gains momentum, her aggressive stance on Medicare expansion and potentially eliminating private health insurance is drawing significant attention. Harris has been a long-standing advocate for Medicare for All, including supporting Bernie Sanders\u2019 bill to eliminate private insurance for all age groups. The ambitious plan by Kamala Harris could have […]<\/p>\n","protected":false},"author":41,"featured_media":58446,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[34606,34609,32109,32113,31919,34608,34607,33653,32112],"class_list":["post-59564","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","tag-abbott-laboratories-abt","tag-consistently-championed","tag-cvs-health-corporation-cvs","tag-inc-tdoc","tag-johnson-johnson-jnj","tag-medicare-for-all-act-of-2017","tag-my-plan-for-medicare-for-all","tag-stated","tag-teladoc-health"],"yoast_head":"\nMedicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog<\/title>\n<meta name=\"description\" content=\"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog\" \/>\n<meta property=\"og:description\" content=\"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\" \/>\n<meta property=\"og:site_name\" content=\"INO.com Trader's Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inocom\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-05T10:00:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-19T13:02:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"The INO.com Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"The INO.com Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\"},\"author\":{\"name\":\"The INO.com Team\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\"},\"headline\":\"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments\",\"datePublished\":\"2024-08-05T10:00:07+00:00\",\"dateModified\":\"2024-08-19T13:02:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\"},\"wordCount\":1136,\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg\",\"keywords\":[\"Abbott Laboratories (ABT)\",\"consistently championed\",\"CVS Health Corporation (CVS)\",\"Inc. (TDOC)\",\"Johnson & Johnson (JNJ)\",\"Medicare for All Act of 2017\",\"my plan for Medicare for all\",\"stated\",\"Teladoc Health\"],\"articleSection\":[\"General\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\",\"url\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\",\"name\":\"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog\",\"isPartOf\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg\",\"datePublished\":\"2024-08-05T10:00:07+00:00\",\"dateModified\":\"2024-08-19T13:02:40+00:00\",\"description\":\"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage\",\"url\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg\",\"contentUrl\":\"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg\",\"width\":1200,\"height\":630},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ino.com\/blog\/#website\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"name\":\"INO.com Trader's Blog\",\"description\":\"Expert Charts, Trading Tips and Technical Analysis from INO.com\",\"publisher\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ino.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ino.com\/blog\/#organization\",\"name\":\"INO.com Trader's Blog\",\"url\":\"https:\/\/www.ino.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"contentUrl\":\"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg\",\"width\":400,\"height\":472,\"caption\":\"INO.com Trader's Blog\"},\"image\":{\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/inocom\/\",\"https:\/\/www.linkedin.com\/company-beta\/1056449\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280\",\"name\":\"The INO.com Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg\",\"caption\":\"The INO.com Team\"},\"url\":\"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog","description":"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/","og_locale":"en_US","og_type":"article","og_title":"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog","og_description":"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...","og_url":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/","og_site_name":"INO.com Trader's Blog","article_publisher":"https:\/\/www.facebook.com\/inocom\/","article_published_time":"2024-08-05T10:00:07+00:00","article_modified_time":"2024-08-19T13:02:40+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg","type":"image\/jpeg"}],"author":"The INO.com Team","twitter_card":"summary_large_image","twitter_misc":{"Written by":"The INO.com Team","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#article","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/"},"author":{"name":"The INO.com Team","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280"},"headline":"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments","datePublished":"2024-08-05T10:00:07+00:00","dateModified":"2024-08-19T13:02:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/"},"wordCount":1136,"publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg","keywords":["Abbott Laboratories (ABT)","consistently championed","CVS Health Corporation (CVS)","Inc. (TDOC)","Johnson & Johnson (JNJ)","Medicare for All Act of 2017","my plan for Medicare for all","stated","Teladoc Health"],"articleSection":["General"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/","url":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/","name":"Medicare for All: How Harris' Plan Could Reshape Healthcare Investments - INO.com Trader's Blog","isPartOf":{"@id":"https:\/\/www.ino.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage"},"image":{"@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg","datePublished":"2024-08-05T10:00:07+00:00","dateModified":"2024-08-19T13:02:40+00:00","description":"As Kamala Harris\u2019s stance on Medicare expansion and the potential elimination of private insurance gains traction, it could dramatically reshape the U.S. healthcare landscape. Discover how this ambitious plan might influence healthcare stocks like CVS Health (CVS), Teladoc Health (TDOC), Abbott (ABT), and Johnson & Johnson (JNJ). Read on to learn more...","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/2024\/08\/medicare-for-all-how-harris-plan-could-reshape-healthcare-investments\/#primaryimage","url":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg","contentUrl":"https:\/\/wwwtest.ino.com\/blog\/wp-content\/uploads\/2023\/04\/pharmadrug.jpeg","width":1200,"height":630},{"@type":"WebSite","@id":"https:\/\/www.ino.com\/blog\/#website","url":"https:\/\/www.ino.com\/blog\/","name":"INO.com Trader's Blog","description":"Expert Charts, Trading Tips and Technical Analysis from INO.com","publisher":{"@id":"https:\/\/www.ino.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ino.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ino.com\/blog\/#organization","name":"INO.com Trader's Blog","url":"https:\/\/www.ino.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","contentUrl":"https:\/\/www.ino.com\/blog\/wp-content\/uploads\/2018\/12\/inologo-400.jpg","width":400,"height":472,"caption":"INO.com Trader's Blog"},"image":{"@id":"https:\/\/www.ino.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/inocom\/","https:\/\/www.linkedin.com\/company-beta\/1056449\/"]},{"@type":"Person","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/d86a8cce826b7bd105200d88bb28a280","name":"The INO.com Team","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ino.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cb06ce065c1db526fc31f4d08d898a30?s=96&d=identicon&r=pg","caption":"The INO.com Team"},"url":"https:\/\/wwwtest.ino.com\/blog\/author\/the-ino-com-team\/"}]}},"_links":{"self":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/59564"}],"collection":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/comments?post=59564"}],"version-history":[{"count":0,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/posts\/59564\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/media\/58446"}],"wp:attachment":[{"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/media?parent=59564"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/categories?post=59564"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wwwtest.ino.com\/blog\/wp-json\/wp\/v2\/tags?post=59564"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}